Clinical Trials Directory

Trials / Completed

CompletedNCT02586480

Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode

Evolution of the PR Interval in Patients Implanted With a Dual Chamber Pacemaker With Algorithm for Spontaneous AV Conduction Preservation

Status
Completed
Phase
Study type
Observational
Enrollment
848 (actual)
Sponsor
LivaNova · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Observational study on long PR interval using the SafeR mode in bradycardia patients.

Detailed description

This observational trial aims to study the evolution of the PR interval in patients implanted with a dual chamber pacemaker with the SafeR mode. The investigators will assess the prevalence and the incidence of PR lengthening and the investigators will study the long PR interval management by physicians, depending on the data embedded in the pacemaker.

Conditions

Interventions

TypeNameDescription
DEVICEdual chamber pacemaker with SafeR algorithmSafeR is an AVB management algorithm: it provides AAI pacing while continuously monitoring AV conduction, it switches to DDD when detecting AVB I, II or III, according to the following criteria: (1) AVB I: 6 long PR intervals, (2) AVB II: 3 blocked atrial events/12 cycles, (3) AVB III: 2 consecutive blocked atrial events. It switches back to AAI mode when needed.

Timeline

Start date
2012-04-01
Primary completion
2015-11-01
Completion
2015-12-01
First posted
2015-10-26
Last updated
2017-10-18

Locations

58 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02586480. Inclusion in this directory is not an endorsement.